Form EFFECT RELMADA THERAPEUTICS,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 9, 2026 4:05 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BTCLOV Appoints Jed Roffers as First Director of Law Enforcement Relations to Strengthen Global Compliance and Security Framework
- New Jersey Digital Agency Synaryverse Integrates AI Into Marketing, Development, and Creative Services
- Best Crypto To Invest In: Blue Chips Wait for the Next Catalyst While AlphaPepe Builds the Pre-Discovery Trade
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
